The good people at the American Journal of Clinical Nutrition (Am J Clin Nutr. 2009;89(1):71-76) have published a L-Carnitine and Cholesterol study done by researchers at the University of Catania, Italy.
Why this is important: Oxidative stress can lead to higher risk for atherosclerosis. A recent study at the University of Minnesota showed that people with high oxidation levels of LDL cholesterol are more likely to develop metabolic syndrome – which can lead to a increased risk of developing heart disease.
The U of M study involved more than 2,000 generally healthy people aged 33-45 (average age 40) for over for five years. Those with the highest levels of oxidized LDL had 3.5 times the risk of developing metabolic syndrome five years later.
When LDL cholesterol is oxidized it can lead to atherosclerosis, which is a plaque on the walls of arteries. Increased inflamation allows the plaque to build up much easier that in a void of inflammation. Causes of increased oxidative stress can range from smoking to running a marathon; a diet void of fruits and vegetables and high in processed or grilled foods.
L-Carnitine continues to show up in diverse studies, reinforcing its many beneficial functions, from neurological protection and function, to fatty acid transport, cell membrane integrity, and now antioxidant effect on cholesterol. I will be on the lookout for studies on LDL / L-Carnitine in healthy populations. (For more on L-Carnitine see our L-Carnitine page.)
As they explain, “the production of peroxide and superoxide is an inevitable consequence of aerobic metabolism, and while these particular ‘reactive oxygen species’ (ROSs) can exhibit a number of biological effects, they are not of themselves excessively reactive and thus they are not especially damaging at physiological concentrations. However, their reactions with poorly liganded iron species can lead to the catalytic production of the very reactive and dangerous hydroxyl radical, which is exceptionally damaging, and a major cause of chronic inflammation.”
Excerpt from the Am J Clin Nutr: They evaluated the efficacy of L-carnitine on the reduction of oxidized low-density lipoprotein (LDL) cholesterol in patients with type 2 diabetes (Am J Clin Nutr. 2009;89(1):71-76). Eighty-one patients with diabetes were randomly assigned to one of two treatment groups for three months. The groups received either 2 g of L-carnitine once daily or a placebo. At the end of the study period, the L-carnitine-treated patients showed significant improvements compared to the placebo group. Oxidized LDL levels decreased by 15.1 compared with 3.0 U/L (P<0.001). The results indicated that oral administration of L-carnitine reduced oxidized LDL cholesterol levels in patients with type 2 diabetes.